PepGen
NASDAQ: PEPG2 known investors
PepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does PepGen do?
- PepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
- Who are PepGen's investors?
- PepGen's investors include Oxford Science Enterprises, RA Capital.